Technology | 2016.04.07
Juno Therapeutics and WuXi AppTec Announce New Company to Develop Novel Cell-Based Cancer Immunotherapies in China
SEATTLE and SHANGHAI, April 7, 2016 /PRNewswire/ -- Juno Therapeutics (NASDAQ: JUNO), a biopharmaceutical company focused on re-engaging the body\'s immune system to revolutionize the treatment of cancer, and WuXi AppTec, a leading open-access R&D capability and technology...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]rapies-in-china-300247765.html
